MCID: END042
MIFTS: 76

Endometrial Carcinoma malady

Genetic diseases, Rare diseases, Cancer diseases, Reproductive diseases categories
Download this MalaCard

Summaries for Endometrial Carcinoma

About this section


Fully expand this MalaCard
Wikipedia:65 Endometrial cancer is cancer that arises from the endometrium (the lining of the uterus or womb). It is... more...

MalaCards based summary: Endometrial Carcinoma, also known as endometrial cancer, is related to endometriosis and papillary carcinoma. An important gene associated with Endometrial Carcinoma is MLH3 (mutL homolog 3), and among its related pathways are VEGF Signaling Pathway and Akt Signaling Pathway. The compounds ici 164384 and idoxifene have been mentioned in the context of this disorder. Affiliated tissues include the tissue lining the uterus, uterus and lymph node, and related mouse phenotypes are limbs/digits/tail and adipose tissue.

Disease Ontology:8 A endometrial cancer that is located in the tissue lining the uterus.

Description from OMIM:46 608089

Aliases & Classifications for Endometrial Carcinoma

About this section

Endometrial Carcinoma, Aliases & Descriptions:

Name: Endometrial Carcinoma 8 44 62
Endometrial Cancer 9 42 22 46 10 44
Endometrioid Carcinoma of Female Reproductive System 8 62
Carcinoma of the Endometrium 8 62
 
Carcinoma, Endometrioid 62
Endometrioid Carcinoma 8
Carcinoma Endometrioid 44


Classifications:



External Ids:

Disease Ontology8 DOID:2871
MeSH34 D018269
OMIM46 608089
NCIt39 C3769
ICD1025 C54.1

Related Diseases for Endometrial Carcinoma

About this section

Diseases in the Endometrial Carcinoma family:

Endometrial Cancer, Familial

Diseases related to Endometrial Carcinoma via text searches within MalaCards or GeneCards/GeneDecks gene sharing:

(show top 50)    (show all 202)
idRelated DiseaseScoreTop Affiliating Genes
1endometriosis31.5PTEN, HOXA10, UCN, ESR1, PGR
2papillary carcinoma31.2PGR, ESR1, CDH1
3breast cancer31.2CDH1, KRAS, ESR1, PGR
4myoma31.1ESR1, PGR
5adenocarcinoma31.1PTEN, ESR1, SULT1E1, PGR, MMP26, KRAS
6ovarian cancer31.1CDH1, MLH1, ESR1, PGR, KRAS, KLK4
7turcot syndrome31.0PTEN, MLH1
8cervical adenocarcinoma31.0ESR1, PGR
9cystadenoma31.0KRAS
10muir-torre syndrome30.9MLH1
11infertility30.9ESR1, TERC, HOXA10
12progesterone resistance30.9ESR1, PGR
13endometrial stromal sarcoma30.9PGR, ESR1
14malignant mixed mullerian tumor30.8KRAS, PGR
15retinoblastoma30.7FGFR2, UCN, KRAS, ESR1, TERC
16pancreatic cancer30.7TERC, KRAS, CDH1
17transitional cell carcinoma30.6CDH1, MLH1, TERC, FGFR2
18colorectal cancer30.4TDGF1P3, KRAS, MSH3, MUTYH, PTEN, MLH1
19melanoma30.3KRAS, CDH1, UCN, TERC, ANG, MLH1
20lung cancer30.2TERC, MUTYH, CDH1, FGFR2, KRAS
21lynch syndrome30.1KRAS, MLH3, MLH1, MUTYH, MSH3
22small cell carcinoma10.7
23adenosquamous carcinoma10.7
24cervicitis10.7
25endotheliitis10.6
26hereditary diffuse gastric cancer10.6CDH1
27cerebral meningioma10.6PGR
28cribriform carcinoma10.6PGR, ESR1
29meningioma10.6PGR, ESR1
30mammary paget's disease10.6ESR1, PGR
31gliomatosis cerebri10.6PTEN
32inflammatory breast carcinoma10.6CDH1, PGR, ESR1
33bilateral breast cancer10.6ESR1, PGR
34breast cancer, invasive ductal10.6ESR1, CDH1, PGR
35ductal carcinoma in situ10.6ESR1, CDH1, PGR
36tubular adenocarcinoma10.6ESR1, CDH1, PGR
37male breast cancer10.6PGR, ESR1
38breast ductal carcinoma10.6ESR1, PGR, CDH1
39adenosarcoma10.6PGR, ESR1
40leiomyomatosis10.6ESR1, PGR
41microinvasive gastric cancer10.6CDH1, MLH1
42familial colorectal cancer10.6MLH1, PTEN
43uterine fibroid10.6PGR, ESR1
44li-fraumeni syndrome10.6MLH1, PTEN
45lymphangioleiomyomatosis10.5PGR, ESR1
46gastric adenocarcinoma10.5MLH1, KRAS, TERC, CDH1
47angiomyolipoma10.5ESR1, PGR
48colon adenocarcinoma10.5KRAS, MLH1, CDH1
49neuroendocrine carcinoma10.5
50verrucous carcinoma10.5

Graphical network of the top 20 diseases related to Endometrial Carcinoma:



Diseases related to endometrial carcinoma

Symptoms for Endometrial Carcinoma

About this section


Clinical features from OMIM:

608089

Drugs & Therapeutics for Endometrial Carcinoma

About this section

Drug clinical trials:

Search ClinicalTrials for Endometrial Carcinoma

Search NIH Clinical Center for Endometrial Carcinoma

Genetic Tests for Endometrial Carcinoma

About this section

Genetic tests related to Endometrial Carcinoma:

id Genetic test Affiliating Genes
1 Endometrial Carcinoma22

Anatomical Context for Endometrial Carcinoma

About this section

MalaCards organs/tissues related to Endometrial Carcinoma:

32
Uterus, Lymph node, Endothelial, Breast, Ovary, Colon, Bone, Testes, Cervix, Testis, T cells, Pituitary, Brain, Retina, Lung

FMA organs/tissues related to Endometrial Carcinoma:

14
The tissue lining the uterus

Animal Models for Endometrial Carcinoma or affiliated genes

About this section

MGI Mouse Phenotypes related to Endometrial Carcinoma:

36 (show all 20)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:000537110.3HOXA10, TERC, PTEN, PGR, ESR1, KRAS
2MP:000537510.3TERC, PTEN, ESRRA, ESR1, FGFR2
3MP:000538010.3TERC, PTEN, PGR, ESR1, KRAS, CDH1
4MP:000538110.2HOXA10, TERC, MLH1, PTEN, ESR1, KRAS
5MP:000539010.2HOXA10, TERC, PTEN, PGR, ESRRA, ESR1
6MP:001077110.2TERC, MLH1, PTEN, PGR, ESR1, MSH3
7MP:000200610.2FGFR2, TERC, MLH1, PTEN, PGR, ESR1
8MP:000118610.1TERC, PTEN, KRAS, FGFR2
9MP:000539710.1TERC, PTEN, SULT1E1, PGR, ESRRA, ESR1
10MP:000536910.1TERC, PTEN, PGR, ESR1, KRAS, FGFR2
11MP:000537910.1HOXA10, TERC, MLH3, MLH1, PTEN, SULT1E1
12MP:000537810.1HOXA10, TERC, PTEN, ESRRA, ESR1, KLK4
13MP:000538910.1HOXA10, TERC, MLH3, MLH1, PTEN, SULT1E1
14MP:000538410.0PGR, PTEN, MLH1, TERC, ESRRA, ESR1
15MP:000538610.0TERC, PTEN, PGR, ESR1, UCN, KLF9
16MP:001076810.0TERC, MLH1, PTEN, PGR, ESR1, MUTYH
17MP:000538710.0KRAS, ESR1, ESRRA, PGR, PTEN, TERC
18MP:00036319.9TERC, PTEN, ESR1, MUTYH, UCN, KRAS
19MP:00053769.8ESRRA, PGR, SULT1E1, PTEN, MLH1, TERC
20MP:00053859.7TERC, PTEN, PGR, ESR1, KRAS, CDH1

Publications for Endometrial Carcinoma

About this section

Articles related to Endometrial Carcinoma:

(show top 50)    (show all 1251)
idTitleAuthorsYear
1
Use of diffusion tensor imaging in assessing superficial myometrial invasion by endometrial carcinoma: a preliminary study. (25332442)
2014
2
Relationship between PTEN, DNA mismatch repair, and tumor histotype in endometrial carcinoma: retained positive expression of PTEN preferentially identifies sporadic non-endometrioid carcinomas. (23599155)
2013
3
Effects of ectopic HER-2/neu gene expression on the COX-2/PGE2/P450arom signaling pathway in endometrial carcinoma cells: HER-2/neu gene expression in endometrial carcinoma cells. (23453006)
2013
4
Secondary analyses from a randomized clinical trial: age as the key prognostic factor in endometrial carcinoma. (24361787)
2013
5
ETV5 cooperates with LPP as a sensor of extracellular signals and promotes EMT in endometrial carcinomas. (22266854)
2012
6
Evaluation of depth of myometrial invasion by magnetic resonance imaging in patients with endometrial carcinoma. (23185792)
2012
7
Uterine endometrial carcinoma: 10 years' experience with long-term follow-up at a single Korean institution. (23075517)
2012
8
Markers for individualised therapy in endometrial carcinoma. (22846840)
2012
9
Weekly paclitaxel-carboplatin regimen in patients with primary advanced or recurrent endometrial carcinoma. (22426408)
2012
10
Aberrant expression of the von Hippel-Lindau gene in human endometrial hyperplasia and endometrial carcinoma. (21436690)
2011
11
Retrospective analysis on coexisting ovarian cancer in 976 patients with clinical stage I endometrial carcinoma. (21314805)
2011
12
Phosphatase and tensin homolog gene inhibits the effect induced by gonadotropin-releasing hormone subtypes in human endometrial carcinoma cells. (20529558)
2010
13
Mast cells: Are they really related to invasiveness of endometrial carcinoma? (20188490)
2010
14
Serum proteomic profile analysis for endometrial carcinoma detection with MALDI-TOF MS. (22371754)
2010
15
Enhanced CD24 expression in endometrial carcinoma and its expression pattern in normal and hyperplastic endometrium. (19130400)
2009
16
Molecular pathology of endometrial carcinoma: practical aspects from the diagnostic and therapeutic viewpoints. (18977806)
2009
17
Endometrial carcinoma clinical management: results of a regional survey. (20099502)
2009
18
Local biosynthesis of estrogen in human endometrial carcinoma through tumor-stromal cell interactions. (19789322)
2009
19
Management of surgical stage III and IV endometrioid endometrial carcinoma: an overview. (19407572)
2009
20
Inhibin-alpha subunit is an independent prognostic parameter in human endometrial carcinomas: analysis of inhibin/activin-alpha, -betaA and -betaB subunits in 302 cases. (19231155)
2009
21
CD10 immunostaining distinguishes atypical polypoid adenomyofibroma (atypical polypoid adenomyoma) from endometrial carcinoma invading the myometrium. (18619643)
2008
22
Immunohistochemical bcl-2 expression, p53 overexpression, PR and ER status in endometrial carcinoma and survival outcomes. (18386458)
2008
23
An exploratory analysis of HER-2 amplification and overexpression in advanced endometrial carcinoma: a Gynecologic Oncology Group study. (17945336)
2008
24
Raloxifene, a selective estrogen receptor modulator, induces mitochondria-mediated apoptosis in human endometrial carcinoma cells. (18807138)
2008
25
Imup-1 and imup-2 overexpression in endometrial carcinoma in Korean and Japanese populations. (18507030)
2008
26
Expression of retinoic acid receptors in human endometrial carcinoma. (18271925)
2008
27
Endometrial carcinoma: pathology and genetics. (17365824)
2007
28
Expression of LIV-1 mRNA in human cervical carcinoma and endometrial carcinoma]. (17959546)
2007
29
Increased expression of hypoxia-inducible factor 1alpha in type I and type II endometrial carcinomas. (17099695)
2007
30
Proteasome inhibitors induce death but activate NF-kappaB on endometrial carcinoma cell lines and primary culture explants. (16735506)
2006
31
Comparison of letrozole and exemestane used in non-adjuvant therapy of endometrial carcinoma]. (15909811)
2005
32
High serum levels of interleukin-6 in endometrial carcinoma are associated with uterine serous papillary histology, a highly aggressive and chemotherapy-resistant variant of endometrial cancer. (15904949)
2005
33
Expression of cancer-testis antigens in endometrial carcinomas using a tissue microarray. (15272278)
2005
34
S100 as an immunohistochemically-detected marker with prognostic significance in endometrial carcinoma. (16033094)
2005
35
A significance of immunohistochemical determination of steroid receptors, cell proliferation factor Ki-67 and protein p53 in endometrial carcinoma. (15047211)
2004
36
VEGF expression and its reguration by p53 gene transfection in endometrial carcinoma cells. (12971625)
2003
37
A phase II trial of anastrozole in advanced recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study. (10926805)
2000
38
PTEN mutations in endometrial carcinomas: a molecular and clinicopathologic analysis of 38 cases. (10746673)
2000
39
Molecular and cytokinetic pretreatment risk assessment in endometrial carcinoma. (10739683)
2000
40
Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma. (10053103)
1999
41
Determination of a normal level of serum CA125 in postmenopausal women as a tool for preoperative evaluation and postoperative surveillance of endometrial carcinoma. (9648586)
1998
42
Differential inhibitory effects on human endometrial carcinoma cell growth of luteinizing hormone-releasing hormone analogues. (9887238)
1998
43
Bcl-2 and p53 expression in stage I endometrial carcinoma. (9854478)
1998
44
Expression of pS2 protein in endometrial carcinomas: correlation with clinicopathologic features and sex steroid receptor status. (9221798)
1997
45
Gi protein activation of gonadotropin-releasing hormone-mediated protein dephosphorylation in human endometrial carcinoma. (9065184)
1997
46
Mutational analysis of the BRCA1 tumor suppressor gene in endometrial carcinoma. (9299260)
1997
47
Overexpression of p53 protein is an independent prognostic indicator in human endometrial carcinoma. (8761370)
1996
48
Decreased E-cadherin expression in endometrial carcinoma is associated with tumor dedifferentiation and deep myometrial invasion. (8188077)
1994
49
Presence of gonadotropin-releasing hormone receptor and its messenger ribonucleic acid in endometrial carcinoma and endometrium. (7959256)
1994
50
Aromatase activity and the effect of estradiol and testosterone on DNA synthesis in endometrial carcinoma cell lines. (8476779)
1993

Variations for Endometrial Carcinoma

About this section

UniProtKB/Swiss-Prot genetic disease variations for Endometrial Carcinoma:

64
id Symbol AA change Variation ID SNP ID
1PTENp.His123TyrVAR_026260

Clinvar genetic disease variations for Endometrial Carcinoma:

6 (show all 12)
id Gene Name Type Significance SNP ID Assembly Location
1CDH1NM_004360.3(CDH1): c.2131C> G (p.Leu711Val)single nucleotide variantPathogenicrs121964871GRCh37Chr 16, 68857496: 68857496
2CDH1NM_004360.3(CDH1): c.1849G> A (p.Ala617Thr)single nucleotide variantPathogenicrs33935154GRCh37Chr 16, 68856041: 68856041
3KRASNM_033360.3(KRAS): c.34G> T (p.Gly12Cys)single nucleotide variantPathogenicrs121913530GRCh37Chr 12, 25398285: 25398285
4KRASNM_033360.3(KRAS): c.40G> A (p.Val14Ile)single nucleotide variantPathogenicrs104894365GRCh37Chr 12, 25398279: 25398279
5FGFR2NM_000141.4(FGFR2): c.755C> G (p.Ser252Trp)single nucleotide variantPathogenicrs79184941GRCh37Chr 10, 123279677: 123279677
6FGFR2NM_000141.4(FGFR2): c.1124A> G (p.Tyr375Cys)single nucleotide variantPathogenicrs121913478GRCh37Chr 10, 123274794: 123274794
7MUTYHNM_001128425.1(MUTYH): c.536A> G (p.Tyr179Cys)single nucleotide variantPathogenicrs34612342GRCh37Chr 1, 45798475: 45798475
8MUTYHNM_001128425.1(MUTYH): c.1187G> A (p.Gly396Asp)single nucleotide variantPathogenicrs36053993GRCh37Chr 1, 45797228: 45797228
9MLH3NM_001040108.1(MLH3): c.2221G> T (p.Val741Phe)single nucleotide variantPathogenicrs28756990GRCh37Chr 14, 75514138: 75514138
10MLH3MLH3, 1-BP DEL, 885GdeletionPathogenic
11PTENNM_000314.4(PTEN): c.253+1G> Asingle nucleotide variantPathogenicGRCh37Chr 10, 89690847: 89690847
12MSH3NM_002439.4(MSH3): c.1148delA (p.Lys383Argfs)deletionPathogenicGRCh38Chr 5, 80675103: 80675103

Expression for genes affiliated with Endometrial Carcinoma

About this section
Expression patterns in normal tissues for genes affiliated with Endometrial Carcinoma

Search GEO for disease gene expression data for Endometrial Carcinoma.

Pathways for genes affiliated with Endometrial Carcinoma

About this section

Pathways related to Endometrial Carcinoma according to GeneCards/GeneDecks:

idSuper pathways (with members indented)ScoreTop Affiliating Genes
1
Show member pathways
10.3FGFR2, KRAS, PTEN
210.3PTEN, KRAS, FGFR2
3
Show member pathways
10.3MLH3, MLH1, MSH3
410.3CDH1, MSH3, MLH1
5
Show member pathways
Nuclear Receptors37
10.2ESR1, ESRRA, PGR
6
Show member pathways
Signaling Pathways in Glioblastoma37
10.2FGFR2, CDH1, KRAS, PTEN
710.2PTEN, ESR1, KRAS, CDH1
8
Show member pathways
10.2FGFR2, PTEN, PGR, ESR1, KRAS
9
Show member pathways
Signal transduction PTEN pathway60
10.2MLH1, PTEN, MSH3, KRAS, CDH1
1010.1CDH1, KRAS, MSH3, PTEN, MLH1, FGFR2

Compounds for genes affiliated with Endometrial Carcinoma

About this section

Compounds related to Endometrial Carcinoma according to GeneCards/GeneDecks:

(show top 50)    (show all 92)
idCompoundScoreTop Affiliating Genes
1ici 1643844410.7PGR, ESR1
2idoxifene4410.7ESR1, PGR
3mononucleotide4410.7PTEN, MSH3, MLH1
4nomegestrol acetate4410.7ESR1, PGR, SULT1E1
5taxane4410.6PTEN, PGR, ESR1
6danazol44 24 1112.6CDH1, ESR1, PGR
7tibolone4410.6SULT1E1, ESR1, PGR
8crcs4410.6PTEN, MLH1, KRAS, CDH1
9trastuzumab44 50 1112.6PTEN, FGFR2, ESR1, PGR
10triphenylethylene4410.6PGR, ESR1
11gefitinib44 50 1112.6PTEN, CDH1, KRAS, ESR1
12o6-methylguanine4410.6CDH1, MLH1, KRAS
13fulvestrant44 50 28 1113.6ESR1, PGR, ESRRA
14ici 182,7806110.6ESRRA, ESR1
15erlotinib44 50 1112.6CDH1, PTEN, KRAS
16indole-3-carbinol4410.6CDH1, ESR1, PTEN
17estrone sulfate44 2411.6SULT1E1, ESR1, PGR
18(z)-4-hydroxytamoxifen6110.6ESRRA, ESR1
19progestin4410.6CDH1, ESR1, PGR, SULT1E1
20ppt61 2811.6ESR1, ESRRA
21cyclophosphamide44 50 1112.6MUTYH, PTEN, ESR1, PGR, FGFR2
22phtpp61 2811.6ESR1, ESRRA
23vitamin d4410.5PTEN, KRAS, ESR1, CDH1, FGFR2
24dpn6110.5ESRRA, ESR1
255-aza-2deoxycytidine4410.5PGR, MLH1, PTEN, ESR1, FGFR2, CDH1
26diethylstilbestrol44 28 1112.5HOXA10, ESR1, ESRRA, PGR, SULT1E1, PTEN
27agar4410.5CDH1, PTEN, PGR, TDGF1P3, TERC, FGFR2
2817beta-hydroxysteroid4410.5ESR1, PGR, SULT1E1
29paclitaxel44 50 1112.5MLH1, CDH1, FGFR2, ESR1, PTEN, PGR
30estradiol44 24 1112.4PGR, HOXA10, MMP26, PTEN, ESR1, SULT1E1
31progestins4410.4ESR1, SULT1E1, PGR
32raloxifene44 50 28 1113.4PGR, ESR1, CDH1
33genistein44 28 61 2 24 1115.4FGFR2, CDH1, ESRRA, PGR, PTEN, SULT1E1
345fluorouracil4410.4CDH1, KRAS, ESR1, TERC, MLH1, PTEN
35deoxyribonucleic acid4410.4MLH1, PTEN, FGFR2
36paraffin4410.4PGR, CDH1, ESR1, KRAS, FGFR2, PTEN
37doxorubicin44 50 1112.4TERC, MLH1, PTEN, PGR, ESR1, MSH3
38panitumumab44 50 1112.4KRAS, PTEN
39vegf4410.4PTEN, ESR1, KRAS, PGR, FGFR2, MLH1
40tamoxifen44 50 28 1113.4ESR1, ESRRA, PGR, SULT1E1, TERC, CDH1
41testosterone44 61 24 1113.3PTEN, SULT1E1, PGR, HOXA10, ESRRA, FGFR2
42cisplatin44 50 61 1113.3ESR1, MUTYH, MSH3, KRAS, CDH1, FGFR2
43pyrimidine44 2411.3ANG, MUTYH, TERC
44steroid4410.2HOXA10, MLH1, PTEN, SULT1E1, PGR, ESRRA
45oxygen44 2411.2MLH1, FGFR2, PTEN, MUTYH, KRAS, ANG
46retinoic acid44 2411.1ESRRA, ESR1, MMP26, KRAS, TDGF1P3, CDH1
47etoposide44 50 61 1113.1TERC, MLH1, PTEN, CDH1
48norgestimate44 1111.0PGR, ESR1
49progesterone44 28 61 24 1114.0ESRRA, PGR, SULT1E1, PTEN, MLH1, TERC
50estrogen449.9MMP26, SULT1E1, PTEN, MLH1, TERC, HOXA10

GO Terms for genes affiliated with Endometrial Carcinoma

About this section

Cellular components related to Endometrial Carcinoma according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1chiasmaGO:00571210.5MLH1, MLH3
2MutLbeta complexGO:03239010.5MLH1, MLH3
3mismatch repair complexGO:03230010.3MLH3, MLH1
4synaptonemal complexGO:00079510.3MLH1, MLH3
5Schmidt-Lanterman incisureGO:04322010.3CDH1, PTEN
6male germ cell nucleusGO:00167310.0MLH1, MLH3
7nucleusGO:0056349.8HOXA10, MLH3, MLH1, PTEN, ESRRA, ESR1

Biological processes related to Endometrial Carcinoma according to GeneCards/GeneDecks:

(show all 14)
idNameGO IDScoreTop Affiliating Genes
1prostate epithelial cord elongationGO:06052310.6FGFR2, ESR1
2prostate epithelial cord arborization involved in prostate glandular acinus morphogenesisGO:06052710.6FGFR2, ESR1
3reciprocal meiotic recombinationGO:00713110.5MLH3, MLH1, MSH3
4negative regulation of epithelial cell proliferationGO:05068010.5PTEN, CDH1, FGFR2
5progesterone receptor signaling pathwayGO:05084710.5KLF9, PGR
6regulation of branching involved in prostate gland morphogenesisGO:06068710.5FGFR2, ESR1
7mismatch repairGO:00629810.5MSH3, MUTYH, MLH1, MLH3
8negative regulation of gene expressionGO:01062910.4PGR, ESR1, UCN
9regulation of osteoblast differentiationGO:04566710.4FGFR2, ESRRA
10response to estradiolGO:03235510.4UCN, ESR1, PTEN
11negative regulation of cell sizeGO:04579210.3UCN, PTEN
12fibroblast growth factor receptor signaling pathwayGO:00854310.3FGFR2, KRAS, PTEN
13positive regulation of nitric-oxide synthase activityGO:05100010.3ESR1, KRAS
14ATP catabolic processGO:00620010.0MSH3, MLH1, MLH3

Molecular functions related to Endometrial Carcinoma according to GeneCards/GeneDecks:

(show all 9)
idNameGO IDScoreTop Affiliating Genes
1MutSalpha complex bindingGO:03240710.5MLH3, MLH1, MUTYH
2guanine/thymine mispair bindingGO:03213710.4MLH1, MSH3
3steroid bindingGO:00549610.4ESR1, ESRRA, PGR, SULT1E1
4mismatched DNA bindingGO:03098310.4MSH3, MLH3
5steroid hormone receptor activityGO:00370710.4ESR1, ESRRA, PGR
6enzyme bindingGO:01989910.2MSH3, ESR1, PGR, PTEN
7single-stranded DNA bindingGO:00369710.2MLH3, MLH1, MSH3
8centromeric DNA bindingGO:01923710.1MSH3, MLH3
9protein bindingGO:0055159.7ESRRA, PGR, PTEN, MLH1, MLH3, HOXA10

Products for genes affiliated with Endometrial Carcinoma

About this section
  • Antibodies
  • Proteins
  • Lysates

Sources for Endometrial Carcinoma

About this section
3CDC
13ExPASy
14FMA
22GTR
23HGMD
24HMDB
25ICD10
26ICD10 via Orphanet
27ICD9CM
28IUPHAR
29KEGG
34MeSH
35MESH via Orphanet
36MGI
39NCIt
40NDF-RT
43NINDS
44Novoseek
46OMIM
47OMIM via Orphanet
51PubMed
52QIAGEN
58SNOMED-CT via Orphanet
62UMLS
63UMLS via Orphanet